CP Stock or CNR Stock: How Did Earnings Stack Up This Week?

Both CNR stock and CP stock came out with earnings this week, so which did better for Motley Fool investors to consider on the TSX today?

| More on:
money cash dividends

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canadian Pacific Railway (TSX:CP)(NYSE:CP) and Canadian National Railway (TSX:CNR)(NYSE:CNI) may both be railway companies, but the similarities ended there this month.

They both have a lot to prove to shareholders in the coming months, even years. One, to prove management knows what it’s doing. And the other, to prove a multi-billion investment was the right move.

So let’s look at CP stock and CNR stock and see how these companies stacked up against each other, and which Motley Fool investors should consider on the TSX today.

The reports

CNR stock came out with its report on October 19. The company declared a “strong quarter” despite the headwinds of wildfires, supply chain issues, and of course COVID-19 disruptions. Revenue was up 5% year over year, with diluted EPS coming in at $2.37 and an increase of 72% year over year! This was all helped by the deal to take over Kansas City Southern falling through but to the pleasure of at least short-term investors on the TSX today.

CNR stock reaffirmed it can deliver both enhanced results this year and beyond, achieving its target of between $3 and $3.3 billion in free cash flow for 2021, which would be on par with 2020.

Meanwhile, CP stock came out with its earnings the next morning on October 20. The company saw revenue increase 5% year over year to $1.94 billion, but a 20% decrease in EPS. Furthermore, the KCS acquisition will up future costs as well, hurt even more from supply chain issues that hurt the company’s performance for the quarter.

That being said, management also remains confident it can deliver “double-digit adjusted EPS growth” for 2021. It continues to target full-year EPS of $3.53, which would be down from 2020’s $3.59.

The response

CNR stock was hit with an attack even before it announced earnings on Tuesday. One of the company’s largest investors announced it believes management should be completely replaced. But while the report targeted several issues with the company, it didn’t have that many solutions.

But that didn’t seem to stop CEO Jean-Jacques Ruest from announcing his “planned” retirement. Whether this means the new CEO will be the choice of TCI Fund Management or not, only time will tell. But clearly, there are a lot of issues at play here that the company needs to solve on the TSX today.

And while CNR stock came in around expectations, CP stock fell below them across the board. EBITDA was 9% below, EPS 9% below, and revenue 4.4% below analyst expectations. Further, given the massive acquisition it has on hand, it doesn’t look like much growth will happen for the company, at least not in the near future.

Foolish takeaway

Still, long-term Motley Fool investors need to consider both of these stocks carefully. CNR stock could have a major shakeup soon that investors should be wary of. That said, it’s in a stronger financial position compared to CP stock.

CP stock on the other hand is now in a fairly poor financial position, especially given the poor performance of this year. Now it has this KCS acquisition to handle. And that being said, long-term investors should see massive revenue a decade or less from now, given the grain and oil KCS runs through.

Both of these stocks are solid long-term plays, with shares likely to continue climbing for years to come. But the choice really falls on your goals. If you can wait, CP stock might be the one for you. If you can’t, CNR stock may be a good option, but I would recommend Motley Fool investors merely add it to a watch list for now amidst all this turmoil.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canadian Pacific Railway Limited. The Motley Fool recommends Canadian National Railway.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »